Dermatan sulfate: New functions from an old glycosaminoglycan

Glycobiology

Volumn 12, Issue 9, 2002, Pages

  Trownbridge, Janet M ^a   Gallo, Richard L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dermatan sulfate; Extracellular matrix; Glycosaminoglycan; Proteoglycans; Skin

Indexed keywords

CHEMOKINE; CYTOKINE; DERMATAN; DERMATAN SULFATE; GLYCOCONJUGATE; GLYCOSAMINOGLYCAN; GROWTH FACTOR; HEPARAN SULFATE;

CARBOHYDRATE ANALYSIS; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CELL ACTIVITY; CELL MEMBRANE; CONTROLLED STUDY; DEVELOPMENT; DISEASE COURSE; EXTRACELLULAR MATRIX; FIBROSIS; HOMEOSTASIS; INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SHORT SURVEY; SKIN; STRUCTURE ANALYSIS; WOUND HEALING;

BLOOD COAGULATION; CARBOHYDRATE SEQUENCE; DERMATAN SULFATE; EXTRACELLULAR MATRIX; GROWTH SUBSTANCES; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE; WOUND HEALING;

MAMMALIA;

EID: 0036744549     PISSN: 09596658     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (94)

1. Ashikari, S., Habuchi, H., and Kimata, K. (1995) Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J. Biol. Chem., 270, 29586-29593.
2. Bechard, D., Gentina, T., Delehedde, M., Scherpereel, A., Lyon, M., Aumercier, M., Vazeux, R., Richet, C., Degand, P., Jude, B., and others. (2001) Endocan is a novel chondroitin sulfate/dermatan sulfate proteoglycan that promotes hepatocyte growth factor/scatter factor mitogenic activity. J. Biol. Chem., 276, 48341-48349.
3. Bernfield, M. and Sanderson, R.D. (1990) Syndecan, a developmentally regulated cell surface proteoglycan that binds extracellular matrix and growth factors. Phil. Trans. R. Soc. Lond. Ser. B, 327, 171-186.
4. Brooks, B., Briggs, D.M., Eastmond, N.C., Fernig, D.G., and Coleman, J.W. (2000) Presentation of IFN-gamma to nitric oxide-producing cells: a novel function for mast cells. J. Immunol., 164, 573-579.
5. Brown, C.T., Nugent, M.A., Lau, F.W., and Trinkaus-Randall, V. (1999) Characterization of proteoglycans synthesized by cultured corneal fibroblasts in response to transforming growth factor beta and fetal calf serum. J. Biol. Chem., 274, 7111-7119.
6. Brown, E.L., Wooten, R.M., Johnson, B.J., Iozzo, R.V., Smith, A., Dolan, M.C., Guo, B.P., Weis, J.J., and Hook, M. (2001) Resistance to Lyme disease in decorin-deficient mice. J. Clin. Invest., 107, 845-852.
7. Burch, G.H., Gong, Y., Liu, W., Dettman, R.W., Curry, C.J., Smith, L., Miller, W.L., and Bristow, J. (1997) Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nature Genet., 17, 104-108.
8. Carrino, D.A., Sorrell, J.M., and Caplan, A.I. (2000) Age-related changes in the proteoglycans of human skin. Arch. Biochem. Biophys., 373, 91-101.
9. Cella, G., Boeri, G., Saggiorato, G., Paolini, R., Luzzatto, G., and Terribile, V.I. (1992) Interaction between histidine-rich glycoprotein and platelet factor 4 with dermatan sulfate and low-molecular-weight dermatan sulfate. Angiology, 43, 59-62.
10. Danielson, K.G., Baribault, H., Holmes, D.F., Graham, H., Kadler, K.E., and Iozzo, R.V. (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J. Cell Biol., 136, 729-743.
11. Day, A.A., Ramis, C.I., Fisher, L.W., Gehron-Robey, P., Termine, J.D., and Young, M.F. (1986) Characterization of bone PG II cDNA and its relationship to PG II mRNA from other connective tissues. Nucleic Acids Res., 14, 9861-9876.
12. De Luca, A., Santra, M., Baldi, A., Giordano, A., and Iozzo, R.V. (1996) Decorin-induced growth suppression is associated with up-regulation of p21, an inhibitor of cyclin-dependent kinases. J. Biol. Chem., 271, 18961-18965.
13. Denholm, E.M., Cauchon, E., Poulin, C., and Silver, P.J. (2000) Inhibition of human dermal fibroblast proliferation by removal of dermatan sulfate. Eur. J. Pharmacol., 400, 145-153.
14. Denholm, E.M., Lin, Y.Q. , and Silver, P.J. (2001) Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion. Eur. J. Pharmacol., 416, 213-221.
15. Denti, A., Sini, P., Tira, M.E., and Balduini, C. (1995) Structural heterogeneity of dermatan sulfate chains: correlation with heparin cofactor II activating properties. Thromb. Res., 79, 187-198.
16. Desnoyers, L., Arnott, D., and Pennica, D. (2001) WISP-1 binds to decorin and biglycan. J. Biol. Chem., 276, 47599-47607.
17. Di Carlo, V., Agnelli, G., Prandoni, P., Coccheri, S., Gensini, G.F., Gianese, F., and Mannucci, P.M. (1999) Dermatan sulphate for the prevention of postoperative venous thromboembolism in patients with cancer. DOS (Dermatan sulphate in Oncologic Surgery) Study Group. Thromb. Haemost., 82, 30-34.
18. DiGabriele, A.D., Lax, I., Chen, D.I., Svahn, C.M., Jaye, M., Schlessinger, J., and Handrickson, W.A. (1998) Structure of a heparin-linked biologically active dimer of fibroblast growth factor. Nature, 393, 812-817.
19. Echtermeyer, F., Streit, M., Wilcox-Adelman, S., Saoncella, S., Denhez, F., Detmar, M., and Goetinck, P. (2001) Delayed wound repair and impaired angiogenesis in mice lacking syndecan- 4. J. Clin. Invest., 107, R9-R14.
20. Elefteriou, F., Exposito, J.Y., Garrone, R., and Lethias, C. (2001) Binding of tenascin-X to decorin. FEBS Lett., 495, 44-47.
21. Elenius, K., Vainio, S., Laato, M., Salmivirta, M., Thesleff, I., and Jalkanen, M. (1991) Induced expression of syndecan in healing wounds. J. Cell Biol., 114, 585-595.
22. Esko, J. (1999a) Genetic disorders of glycosylation in cultured cells. In: Varki, A., Cummings, R., Esko, J., Freeze, H., Hart, G., and Marth, J. (eds.), Essentials of glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 469-477.
23. Esko, J. (1999b) Glycosaminoglycan-binding proteins. In: Varki, A., Esko, J., Freeze, H., Hart, G. and Marth, J. (eds.), Essentials of glycobiology. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 441-453.
24. Esko, J.D. and Lindahl, U. (2001) Molecular diversity of heparan sulfate. J. Clin. Invest., 108, 169-173.
25. Faham, S., Hileman, R.E., Fromm, J.R., Linhardt, R.J., and Rees, D.C. (1996) Heparin structure and interactions with basic fibroblast growth factor. Science, 271, 1116-1120.
26. Fernandez, J.A., Petaja, J., and Griffin, J.H. (1999) Dermatan sulfate and LMW heparin enhance the anticoagulant action of activated protein C. Thromb. Haemost., 82, 1462-1468.
27. Feyzi, E., Saldeen, T., Larsson, E., Lindahl, U., and Salmivirta, M. (1998) Age-dependent modulation of heparan sulfate structure and function. J. Biol. Chem., 273, 13395-13398.
28. Fisher, L.W., Termine, J.D., and Young, M.F. (1989) Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. J. Biol. Chem., 264, 4571-4576.
29. Gallo, R. (1999) Proteoglycans and glycosaminoglycans of skin. In: Freedberg, I., Eisen, A., Wolff, K., Austen, K., Goldsmith, L., Katz, S., and Fitzpatrick, T. (eds.), Dermatology in general mediicne, vol. 1. McGraw-Hill, New York, pp. 283-288.
30. Gallo, R., Kim, C., Kokenyesi, R., Adzick, N.S., and Bernfield, M. (1996) Syndecans-1 and -4 are induced during wound repair of neonatal but not fetal skin. J. Invest. Dermatol., 107, 676-683.
31. Gallo, R.L., Ono, M., Povsic, T., Page, C., Eriksson, E., Klagsbrun, M., and Bernfield, M. (1994) Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl Acad. Sci. USA, 91, 11035-11039.
32. Garg, H., Warren, C., and Siebert, J. (2000) Chemistry of scarring. In: Garg, H. and Longaker, M. (eds.), Scarless wound repair. Marcel Dekker, New York, pp. 1-21.
33. Hildebrand, A., Romaris, M., Rasmussen, L.M., Heinegard, D., Twardzik, D.R., Border, W.A., and Ruoslahti, E. (1994) Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. Biochem. J., 302, 527-534.
34. Hirose, J., Kawashima, H., Yoshie, O., Tashiro, K., and Miyasaka, M. (2001) Versican interacts with chemokines and modulates cellular responses. J. Biol. Chem., 276, 5228-5234.
35. Iozzo, R.V. (1997) The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit. Rev. Biochem. Mol. Biol., 32, 141-174.
36. Iozzo, R.V. (2001) Series introduction: heparan sulfate proteoglycans: intricate molecules with intriguing functions. J. Clin. Invest., 108, 165-167.
37. Iozzo, R.V., Moscatello, D.K., McQuillan, D.J., and Eichstetter, I. (1999) Decorin is a biological ligand for the epidermal growth factor receptor. J. Biol. Chem., 274, 4489-4492.
38. Johnson, H.J., Rosenberg, L., Choi, H.U., Garza, S., Hook, M., and Neame, P.J. (1997) Characterization of epiphycan, a small proteoglycan with a leucine-rich repeat core protein. J. Biol. Chem., 272, 18709-18717.
39. Kim, C., Goldberger, O., Gallo, R., and Bernfield, M. (1994) Members of the syndecan family of heparan sulfate proteoglycans are expressed in distinct cell-, tissue-, and development-specific patterns. Mol. Biol. Cell, 5, 797-805.
40. Kovanen, P.T. and Pentikainen, M.O. (1999) Decorin links low-density lipoproteins (LDL) to collagen: a novel mechanism for retention of LDL in the atherosclerotic plaque. Trends Cardiovasc. Med., 9, 86-91.
41. Kreuger, J., Prydz, K., Pettersson, R.F., Lindahl, U., and Salmivirta, M. (1999) Characterization of fibroblast growth factor 1 binding heparan sulfate domain. Glycobiology, 9, 723-729.
42. Krumdieck, R., Hook, M., Rosenberg, L.C., and Volanakis, J.E. (1992) The proteoglycan decorin binds C1q and inhibits the activity of the C1 complex. J. Immunol., 149, 3695-3701.
43. Kuschert, G.S., Coulin, F., Power, C.A., Proudfoot, A.E., Hubbard, R.E., Hoogewerf, A.J., and Wells, T.N. (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry, 38, 12959-12968.
44. Lee, R.T., Yamamoto, C., Feng, Y., Potter-Perigo, S., Briggs, W.H., Landschulz, K.T., Turi, T.G., Thompson, J.F., Libby, P., and Wight, T.N. (2001) Mechanical strain induces specific changes in the synthesis and organization of proteoglycans by vascular smooth muscle cells. J. Biol. Chem., 276, 13847-13951.
45. Liaw, P.C., Becker, D.L., Stafford, A.R., Fredenburgh, J.C., and Weitz, J.I. (2001) Molecular basis for the susceptibility of fibrin-bound thrombin to inactivation by heparin cofactor ii in the presence of dermatan sulfate but not heparin. J. Biol. Chem., 276, 20959-20965.
46. Litwack, E., Ivins, J., Kumbasar, A., Paine-Saunders, S., Stipp, C., and Lander, A. (1998) Expression of the heparan sulfate proteoglycan glypican-1 in the developing rodent. Dev. Dyn., 211, 72-87.
47. Lyon, M., Deakin, J.A., Mizuno, K., Nakamura, T., and Gallagher, J.T. (1994) Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem., 269, 11216-11223.
48. Lyon, M., Deakin, J.A., Rahmoune, H., Fernig, D.G., Nakamura, T., and Gallagher, J.T. (1998) Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate. J. Biol. Chem., 273, 271-278.
49. Maimone, M.M. and Tollefsen, D.M. (1990) Structure of a dermatan sulfate hexasaccharide that binds to heparin cofactor II with high affinity. J. Biol. Chem., 265, 18263-18271.
50. Maione, T.E., Gray, G.S., Petro, J., Hunt, A.J., Donner, A.L., Bauer, S.I., Carson, H.F., and Sharpe, R.J. (1990) Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science, 247, 77-79.
51. Martin, L., Blanpain, C., Garnier, P., Wittamer, V., Parmentier, M., and Vita, C. (2001) Structural and functional analysis of the RANTES-glycosaminoglycans interactions. Biochemistry, 40, 6303-6318.
52. Mascellani, G., Liverani, L., Bianchini, P., Parma, B., Torri, G., Bisio, A., Guerrini, M., and Casu, B. (1993) Structure and contribution to the heparin cofactor II-mediated inhibition of thrombin of naturally oversulphated sequences of dermatan sulphate. Biochem. J., 296, 639-648.
53. Matsumoto, K. and Nakamura, T. (1996) Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. (Tokyo), 119, 591-600.
54. Merry, C.L., Lyon, M., Deakin, J.A., Hopwood, J.J., and Gallagher, J.T. (1999) Highly sensitive sequencing of the sulfated domains of heparan sulfate. J. Biol. Chem., 274, 18455-18462.
55. Mongiat, M., Taylor, K., Otto, J., Aho, S., Uitto, J., Whitelock, J.M., and Iozzo, R.V. (2000) The protein core of the proteoglycan perlecan binds specifically to fibroblast growth factor-7. J. Biol. Chem., 275, 7095-7100.
56. Moscatello, D.K., Santra, M., Mann, D.M., McQuillan, D.J., Wong, A.J., and Iozzo, R.V. (1998) Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J. Clin. Invest., 101, 406-412.
57. Nelimarkka, L., Salminen, H., Kuopio, T., Nikkari, S., Ekfors, T., Laine, J., Pelliniemi, L., and Jarvelainen, H. (2001) Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am. J. Pathol., 158, 345-353.
58. Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R.A., Pestonjamasp, V., Piraino, J., Huttner, K. and Gallo, R.L. (2001) Innate antimicrobial peptide protects the skin from invasive bacterial infection. Nature, 414, 454-457.
59. Ornitz, D.M. and Itoh, N. (2001) Fibroblast growth factors. Genome Biol., 2.
60. Park, P.W., Pier, G.B., Hinkes, M.T., and Bernfield, M. (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature, 411, 98-102.
61. Penc, S.F., Pomahac, B., Eriksson, E., Detmar, M., and Gallo, R.L. (1999) Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1. J. Clin. Invest., 103, 1329-1335.
62. Penc, S.F., Pomahac, B., Winkler, T., Dorschner, R.A., Eriksson, E., and Gallo, R.L. (1998) Dermatan Sulfate released after injury is a potent promoter of FGF-2 activity. J. Biol. Chem., 273, 28116-28121.
63. Pentikainen, M.O., Oorni, K., Lassila, R., and Kovanen, P.T. (1997) The proteoglycan decorin links low density lipoproteins with collagen type I. J. Biol. Chem., 272, 7633-7638.
64. Petaja, J., Fernandez, J.A., Gruber, A., and Griffin, J.H. (1997) Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C. J. Clin. Invest., 99, 2655-2663.
65. Preissner, K.T., Koyama, T., Muller, D., Tschopp, J., and Muller-Berghaus, G. (1990) Domain structure of the endothelial cell receptor thrombomodulin as deduced from modulation of its anticoagulant functions. Evidence for a glycosaminoglycan-dependent secondary binding site for thrombin. J. Biol. Chem., 265, 4915-4922.
66. Priglinger, U., Geiger, M., Bielek, E., Vanyek, E., and Binder, B.R. (1994) Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598). The role of glycosaminoglycans present on the luminal cell surface. J. Biol. Chem., 269, 14705-14710.
67. Proudfoot, A.E., Fritchley, S., Borlat, F., Shaw, J.P., Vilbois, F., Zwahlen, C., Trkola, A., Marchant, D., Clapham, P.R., and Wells, T.N. (2001) The BBXB motif of RANTES is the principal site for heparin binding and controls receptor selectivity. J. Biol. Chem., 276, 10620-10626.
68. Rapraeger, A. (1989) Transforming growth factor (type beta) promotes the addition of chondroitin sulfate chains to the cell surface proteoglycan (syndecan) of mouse mammary epithelia. J. Cell Biol., 109, 2509-2518.
69. Rhomberg, A.J., Ernst, S., Sasisekharan, R., and Biemann, K. (1998) Mass spectrometric and capillary electrophoretic investigation of the enzymatic degradation of heparin-like glycosaminoglycans. Proc. Natl Acad. Sci. USA, 95, 4176-4181.
70. Rostand, K.S. and Esko, J.D. (1997) Microbial adherence to and invasion through proteoglycans. Infect. Immun., 65, 1-8.
71. Santra, M., Eichstetter, I., and Iozzo, R.V. (2000) An anti-oncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J. Biol. Chem., 275, 35153-35161.
72. Santra, M., Mann, D.M., Mercer, E.W., Skorski, T., Calabretta, B., and Iozzo, R.V. (1997) Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. J. Clin. Invest., 100, 149-157.
73. Sawitzky, D. (1996) Protein-glycosaminoglycan interactions: infectiological aspects. Med. Microbiol. Immunol. (Berl), 184, 155-161.
74. Schlessinger, J., Plotnikov, AX, Ibrahimi, O.A., Eliseenkova, A.V., Yeh, B.K., Yayon, A., Linhardt, R.J., and Mohammadi, M. (2000) Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell, 6, 743-750.
75. Schmidt, A., Skaletz-Rorowski, A., and Buddecke, E. (1995) Basic fibroblast growth factor controls the expression and molecular structure of heparan sulfate in corneal endothelial cells. Eur. J. Biochem., 234, 479-484.
76. Schmidt, G., Robenek, H., Harrach, B., Glossl, J., Nolte, V., Hormann, H., Richter, H., and Kresse, H. (1987) Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin. J. Cell Biol., 104, 1683-1691.
77. Schmidtchen, A., Frick, I., and Bjorck, L. (2001) Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol., 39, 708-713.
78. Scully, M.F., Ellis, V., Seno, N., and Kakkar, V.V. (1988) Effect of oversulphated chondroitin and dermatan sulphate upon thrombin and factor Xa inactivation by antithrombin III or heparin cofactor II. Biochem. J., 254, 547-551.
79. Sergeant, N., Lyon, M., Rudland, P.S., Fernig, D.G., and Delehedde, M. (2000) Stimulation of DNA synthesis and cell proliferation of human mammary myoepithelial-like cells by hepatocyte growth factor/scatter factor depends on heparan sulfate proteoglycans and sustained phosphorylation of mitogen-activated protein kinases p42/44. J. Biol. Chem., 275, 17094-17099.
80. Shirk, R.A., Parthasarathy, N., San Antonio, J.D., Church, F.C., and Wagner, W.D. (2000) Altered dennatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J. Biol. Chem., 275, 18085-18092.
81. Stanley, P. and Ioffe, E. (1995) Glycosyltransferase mutants: key to new insights in glycobiology. FASEB J., 9, 1436-1444.
82. Tollefsen, D.M., Peacock, M.E., and Monafo, W.J. (1986) Molecular size of dermatan sulfate oligosaccharides required to bind and activate heparin cofactor II. J. Biol. Chem., 261, 8854-8858.
83. Tumova, S., Woods, A., and Couchman, J.R. (2000a) Heparan sulfate chains from glypican and syndecans bind the Hep II domain of fibronectin similarly despite minor structural differences. J. Biol. Chem., 275, 9410-9417.
84. Tumova, S., Woods, A., and Couchman, J.R. (2000b) Heparan sulfate proteoglycans on the cell surface: versatile coordinators of cellular functions. Int. J. Biochem. Cell Biol., 32, 269-288.
85. Turnbull, J., Powell, A., and Guimond, S. (2001) Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol., 11, 75-82.
86. Turnbull, J.E., Hopwood, J.J., and Gallagher, J.T. (1999) A strategy for rapid sequencing of heparan sulfate and heparin saccharides. Proc. Natl Acad. Sci. USA, 96, 2698-2703.
87. Vives, R.R., Pye, D.A., Salmivirta, M., Hopwood, J.J., Lindahl, U., and Gallagher, J.T. (1999) Sequence analysis of heparan sulphate and heparin oligosaccharides. Biochem. J., 339, 767-773.
88. Walker, A. and Gallagher, J.T. (1996) Structural domains of heparan sulfate for specific recognition of the C-terminal heparin-binding domain of human plasma fibronectin (HEPII). Biochem. J., 317, 871-877.
89. Westergren-Thorsson, G., Onnervik, P.O., Fransson, L.A., and Malmstrom, A. (1991) Proliferation of cultured fibroblasts is inhibited by L-iduronate-containing glycosaminoglycans. J. Cell Physiol., 147, 523-530.
90. Westergren-Thorsson, G., Schmidtchen, A., Sarnstrand, B., Fransson, L.A., and Malmstrom, A. (1992) Transforming growth factor-beta induces selective increase of proteoglycan production and changes in the copolymeric structure of dermatan sulphate in human skin fibroblasts. Eur. J. Biochem., 205, 277-286.
91. Winnemoller, M., Schon, P., Vischer, P., and Kresse, H. (1992) Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. Eur. J. Cell Biol., 59, 47-55.
92. Yamaguchi, Y., Mann, D.M., and Ruoslahti, E. (1990) Negative regulation of transforming growth factor-beta by the proteoglycan decorin. Nature, 346, 281-284.
93. Yeo, T.K., Brown, L., and Dvorak, H.F. (1991) Alterations in proteoglycan synthesis common to healing wounds and tumors. Am. J. Pathol., 138, 1437-1450.
94. Zimmermann, D.R. and Ruoslahti, E. (1989) Multiple domains of the large fibroblast proteoglycan, versican. EMBO J., 8, 2975-2981.